- Trump-era tariffs may benefit AI stocks, while Google faces DOJ rulings and secures a default search engine deal with Apple.
- AI stocks are benefiting from the trend of onshoring and tariffs implemented during the Trump era.
- AI stocks benefit from Trump tariffs and onshoring.
- A value investment strategy highlighted Corpay as a holding while underperforming its benchmark index, amidst AI stocks benefiting from Trump tariffs.
A patient capital strategy highlighted UnitedHealth Group as a top holding while benefiting from Trump-era tariffs on undervalued AI stocks.
1 report, 1 independent
Updated Jul 18
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A patient capital strategy highlighted UnitedHealth Group as a top holding while benefiting from Trump-era tariffs on undervalued AI stocks.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
Related events
- AI stocks are benefiting from Trump-era tariffs, with Morningstar and ClearBridge providing market analysis on growth and upside potential.
- Barclays raised its price target for Okta, noting that AI stocks are benefiting from the onshoring trend and Trump-era tariffs.
- AI stocks are benefiting from Trump-era tariffs, and Brian Schwartz maintained an Outperform rating on Workday on September 5th.
- Trump's policies, including tariffs and onshoring, are being discussed in the context of their potential benefits for AI stocks, with specific attention paid to Moderna's performance and guidance.
- SharpLink Gaming acquired Ethereum above market prices, causing a stock price drop, while Trump tariffs continue to benefit AI stocks.
Coverage
Newest first; wire copies grouped- Insider MonkeyPatient Capital Opportunity Equity Strategy Initiated a Position in UnitedHealth Group Incorporated (UNH) on a Dip Patient Capital Management, a value investing firm, released its “Patient Capital Op